These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4031113)
1. Excretion of triamterene and its metabolite in triamterene stone patients. Ettinger B J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113 [TBL] [Abstract][Full Text] [Related]
2. The true composition of kidney stones passed during triamterene therapy. Sörgel F; Ettinger B; Benet LZ J Urol; 1985 Nov; 134(5):871-3. PubMed ID: 4057369 [TBL] [Abstract][Full Text] [Related]
3. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. Werness PG; Bergert JH; Smith LH J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920 [TBL] [Abstract][Full Text] [Related]
4. [Drug induced nephrolithiasis: observation of an oxalate and hydroxylated triamterene stone (author's transl)]. Baudin S; Rodrigue H Nephrologie; 1980; 1(4):183-5. PubMed ID: 7301028 [TBL] [Abstract][Full Text] [Related]
5. Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis. Sörgel F; Ettinger B; Benet LZ J Pharm Sci; 1986 Feb; 75(2):129-32. PubMed ID: 3958920 [TBL] [Abstract][Full Text] [Related]
6. Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide. Spence JD; Wong DG; Lindsay RM Lancet; 1985 Jul; 2(8446):73-5. PubMed ID: 2861527 [TBL] [Abstract][Full Text] [Related]